MOSAIC at the 2024 Nigeria HIV Prevention Conference
A MOSAIC Success story
MOSAIC made significant contributions to the 2024 Nigeria HIV Prevention Conference through two dynamic panel sessions. Kicking off the three-day event, the Youth Conference on May 7th centered on the theme “Adolescents and Young People as Agents of Change.” NextGen Squad member.
Adaobi Olisa, skillfully led a panel discussion titled “Gen-N: Integrating Sustainable HIV Prevention Strategies for Adolescents and Young People.” The panel featured representatives from prominent Youth-led CSOs and implementing partners such as the Youth Network on HIV/AIDS in Nigeria (NYNETHA), Education as a Vaccine (EVA), THE PACT, and the Focal Desk Officer for the Adolescent and Young People program at the Nigeria National Agency for the Control of AIDS (NACA). Their discussions shed light on the challenges faced by young people in accessing HIV prevention services, proposing innovative solutions utilizing the Gen-N platform.
Transitioning to the main conference on May 8th, MOSAIC facilitated another insightful panel session titled “Harnessing the Power of Collaboration: Multi-Stakeholder Partnerships for CAB PrEP Roll-Out in Nigeria.” Dr. Helen Anyasi, MOSAIC Nigeria’s Project Director, steered the discussion which featured a diverse panel representing key stakeholders. Among them were Taiwo Olakunle, Assistant Director and head of the PrEP & STI Unit of the National HIV/AIDS, Viral Hepatitis and STI Control Program (NASCP), Pharm Uchenna Elemuwa, Director of Pharmacovigilance at the National Agency for Food and Drug Administration and Control (NAFDAC), Angela Agweye, USAID Nigeria Activity Manager for the MOSAIC project, Durueke Florita, Executive Director of the New HIV Vaccine and Microbicides Advocacy Society (NHVMAS), Joseph Ashivor, Technical Director of the GF N-THRIP Project at the Society for Family Health (SFH), and Oluwakemi Sowale, an Associate at the Clinton Health Access Initiative (CHAI).
Together, they shared valuable insights and early learnings from efforts to expand HIV prevention method choice through the introduction of the long-acting injectable Cabotegravir (CAB PrEP) in Nigeria.
Both sessions served as platforms for stakeholders to convene and exchange valuable insights on the advancements in HIV prevention strategies in Nigeria.
Quotes from Panelists
